PHASE II STUDY OF SINGLE AGENT CLOFARABINE IN PREVIOUSLY UNTREATED OLDER ADULT PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML) UNLIKELY TO BENEFIT FROM STANDARD INDUCTION CHEMOTHERAPY
Publication
, Conference
Erba, H; Kantarjian, H; Claxton, D; Arellano, M; Lyons, R; Kovacsovics, T; Gabrilove, J; Eckert, S; Abichandani, R; Faderl, S
Published in: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
June 1, 2008
Duke Scholars
Published In
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
EISSN
1592-8721
ISSN
0390-6078
Publication Date
June 1, 2008
Volume
93
Start / End Page
354 / 354
Location
Copenhagen, DENMARK
Publisher
FERRATA STORTI FOUNDATION
Conference Name
13th Congress of the European-Hematology-Association
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Erba, H., Kantarjian, H., Claxton, D., Arellano, M., Lyons, R., Kovacsovics, T., … Faderl, S. (2008). PHASE II STUDY OF SINGLE AGENT CLOFARABINE IN PREVIOUSLY UNTREATED OLDER ADULT PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML) UNLIKELY TO BENEFIT FROM STANDARD INDUCTION CHEMOTHERAPY. In HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (Vol. 93, pp. 354–354). Copenhagen, DENMARK: FERRATA STORTI FOUNDATION.
Erba, H., H. Kantarjian, D. Claxton, M. Arellano, R. Lyons, T. Kovacsovics, J. Gabrilove, S. Eckert, R. Abichandani, and S. Faderl. “PHASE II STUDY OF SINGLE AGENT CLOFARABINE IN PREVIOUSLY UNTREATED OLDER ADULT PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML) UNLIKELY TO BENEFIT FROM STANDARD INDUCTION CHEMOTHERAPY.” In HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 93:354–354. FERRATA STORTI FOUNDATION, 2008.
Erba H, Kantarjian H, Claxton D, Arellano M, Lyons R, Kovacsovics T, et al. PHASE II STUDY OF SINGLE AGENT CLOFARABINE IN PREVIOUSLY UNTREATED OLDER ADULT PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML) UNLIKELY TO BENEFIT FROM STANDARD INDUCTION CHEMOTHERAPY. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. FERRATA STORTI FOUNDATION; 2008. p. 354–354.
Erba, H., et al. “PHASE II STUDY OF SINGLE AGENT CLOFARABINE IN PREVIOUSLY UNTREATED OLDER ADULT PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML) UNLIKELY TO BENEFIT FROM STANDARD INDUCTION CHEMOTHERAPY.” HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, vol. 93, FERRATA STORTI FOUNDATION, 2008, pp. 354–354.
Erba H, Kantarjian H, Claxton D, Arellano M, Lyons R, Kovacsovics T, Gabrilove J, Eckert S, Abichandani R, Faderl S. PHASE II STUDY OF SINGLE AGENT CLOFARABINE IN PREVIOUSLY UNTREATED OLDER ADULT PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML) UNLIKELY TO BENEFIT FROM STANDARD INDUCTION CHEMOTHERAPY. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. FERRATA STORTI FOUNDATION; 2008. p. 354–354.
Published In
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
EISSN
1592-8721
ISSN
0390-6078
Publication Date
June 1, 2008
Volume
93
Start / End Page
354 / 354
Location
Copenhagen, DENMARK
Publisher
FERRATA STORTI FOUNDATION
Conference Name
13th Congress of the European-Hematology-Association
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology